Stock Analyses

Model-driven valuations for thousands of US-listed stocks, built from SEC EDGAR filings. Click any card to see the full analysis.

All sectors 6,479 Financial Services 1,900 Healthcare 1,116 Technology 1,079 Industrials 668 Consumer Cyclical 490 Basic Materials 337 Consumer Defensive 248 Communication Services 213 Utilities 183 Energy 165 Real Estate 80
Clear
6,990 stocks · page 115 of 117
Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
WYFI
WhiteFiber, Inc.
Valuation N/A
Financial Services
Price$17.59
Model IV—
P/IV—
Market implies +29.1%/yr vs model +50.0% · below model
WYHG
Wing Yip Food Holdings Group Ltd
Deeply overvalued
Consumer Defensive
Price$4.13
Model IV$0.78
P/IV1.04
Premium +429% Return to IV: -81.1%
Market implies +14.8%/yr vs model +2.0% · above model
WYNN
WYNN RESORTS LTD
Deeply undervalued
Consumer Cyclical
Price$81.68
Model IV$159.24
P/IV0.64
Discount 49% Return to IV: +95.0%
Owner yield 9.8% 10-yr IRR 26.1% · grower
Market implies +3.7%/yr vs model +16.7% · below model
WYY
WIDEPOINT CORP
Deeply overvalued
Technology
Price$10.83
Model IV$8.06
P/IV1.40
Premium +34% Return to IV: -25.6%
Owner yield 2.4% 10-yr IRR 4.1% · grower
Market implies +12.8%/yr vs model +13.8% · in line
XAIR
Beyond Air, Inc.
Deeply overvalued
Healthcare
Price$3.14
Model IV$0.58
P/IV0.80
Premium +444% Return to IV: -81.6%
Market implies +9.0%/yr vs model +43.5% · below model
XBIO
Xenetic Biosciences, Inc.
Deeply overvalued
Healthcare
Price$3.90
Model IV$2.04
P/IV1.54
Premium +91% Return to IV: -47.7%
Market implies +7.6%/yr vs model +26.5% · below model
XBIT
XBiotech Inc.
Valuation N/A
Healthcare
Price$2.19
Model IV—
P/IV—
Market implies +31.0%/yr vs model +15.0% · above model
XBP
XBP Global Holdings, Inc.
Deeply undervalued
Technology
Price$2.99
Model IV$8.50
P/IV0.29
Discount 65% Return to IV: +184.2%
Market implies -9.4%/yr vs model +12.0% · below model
XBPEW
XBP Global Holdings, Inc.
Valuation N/A
Technology
Price$0.03
Model IV—
P/IV—
Market implies -50.0%/yr vs model +12.0% · below model
XCBE
X3 Acquisition Corp. Ltd.
Valuation N/A
Financial Services
Price$10.01
Model IV—
P/IV—
XCH
XCHG Ltd
Valuation N/A
Technology
Price$3.14
Model IV—
P/IV—
Market implies +93.8%/yr vs model +2.0% · above model
XCUR
EXICURE, INC.
Valuation N/A
Healthcare
Price$1.31
Model IV—
P/IV—
Market implies +28.7%/yr vs model +15.0% · above model
XE
X-Energy, Inc.
Valuation N/A
Industrials
Price$15.64
Model IV—
P/IV—
XEL
XCEL ENERGY INC
Fairly valued
Utilities
Price$72.30
Model IV$75.54
P/IV1.05
Discount 4% Return to IV: +4.5%
XELB
XCel Brands, Inc.
Deeply overvalued
Financial Services
Price$0.89
Model IV$0.47
P/IV4.68
Premium +91% Return to IV: -47.7%
XELLL
XCEL ENERGY INC
Deeply undervalued
Utilities
Price$21.83
Model IV$52.98
P/IV0.44
Discount 59% Return to IV: +142.7%
XENE
Xenon Pharmaceuticals Inc.
Valuation N/A
Healthcare
Price$58.65
Model IV—
P/IV—
Market implies +111.3%/yr vs model +2.0% · above model
XERS
Xeris Biopharma Holdings, Inc.
Deeply undervalued
Healthcare
Price$7.45
Model IV$17.20
P/IV0.36
Discount 57% Return to IV: +130.8%
Market implies -15.7%/yr vs model +50.0% · below model
XFLH
XFLH Capital Corp
Valuation N/A
Financial Services
Price$10.00
Model IV—
P/IV—
XFLT
XAI Floating Rate & Alternative Income Trust
Valuation N/A
Unknown
Price$19.52
Model IV—
P/IV—
XFOR
X4 Pharmaceuticals, Inc
Valuation N/A
Healthcare
Price$3.62
Model IV—
P/IV—
Market implies +38.9%/yr vs model +15.0% · above model
XGN
EXAGEN INC.
Deeply overvalued
Healthcare
Price$7.35
Model IV$1.92
P/IV2.59
Premium +283% Return to IV: -73.9%
Market implies +17.3%/yr vs model +8.4% · above model
XHG
XChange TEC.INC
Valuation N/A
Financial Services
Price$3.02
Model IV—
P/IV—
Market implies +137.9%/yr vs model +2.0% · above model
XHLD
TEN Holdings, Inc.
Valuation N/A
Technology
Price$12.53
Model IV—
P/IV—
Market implies +64.2%/yr vs model +2.0% · above model
XHR
Xenia Hotels & Resorts, Inc.
Deeply undervalued
Consumer Cyclical
Price$17.65
Model IV$48.35
P/IV0.36
Discount 63% Return to IV: +173.9%
Market implies -1.8%/yr vs model +16.8% · below model
XIFR
XPLR Infrastructure, LP
Deeply overvalued
Utilities
Price$11.40
Model IV$4.65
P/IV2.68
Premium +145% Return to IV: -59.2%
XLO
Xilio Therapeutics, Inc.
Fairly valued
Healthcare
Price$8.93
Model IV$8.45
P/IV1.00
Premium +6% Return to IV: -5.3%
Market implies -7.3%/yr vs model +15.0% · below model
XMAX
XMax Inc.
Valuation N/A
Consumer Cyclical
Price$8.55
Model IV—
P/IV—
Market implies +19.4%/yr vs model +7.4% · above model
XMTR
Xometry, Inc.
Deeply overvalued
Technology
Price$86.11
Model IV$49.08
P/IV1.94
Premium +75% Return to IV: -43.0%
Market implies +12.7%/yr vs model +33.2% · below model
XNCR
Xencor Inc
Valuation N/A
Healthcare
Price$24.41
Model IV—
P/IV—
Market implies +65.5%/yr vs model +2.0% · above model
XNDU
Xanadu Quantum Technologies Ltd
Valuation N/A
Technology
Price$8.02
Model IV—
P/IV—
XNET
Xunlei Ltd
Valuation N/A
Technology
Price$4.90
Model IV—
P/IV—
Owner yield 1.5% 10-yr IRR -0.1% · grower
Market implies +34.3%/yr vs model +17.6% · above model
XOM
EXXON MOBIL CORP
Deeply overvalued
Energy
Price$163.54
Model IV$104.62
P/IV1.59
Premium +56% Return to IV: -36.0%
Owner yield 4.2% 10-yr IRR 4.0% · steady
Market implies +9.5%/yr vs model +3.9% · above model
XOMA
XOMA Royalty Corp
Valuation N/A
Healthcare
Price$40.17
Model IV—
P/IV—
Market implies +69.6%/yr vs model +2.0% · above model
XOMAO
XOMA Royalty Corp
Valuation N/A
Healthcare
Price$25.00
Model IV—
P/IV—
Market implies +72.6%/yr vs model +2.0% · above model
XOMAP
XOMA Royalty Corp
Valuation N/A
Healthcare
Price$24.98
Model IV—
P/IV—
Market implies +37.2%/yr vs model +2.0% · above model
XOS
Xos, Inc.
Valuation N/A
Consumer Cyclical
Price$2.71
Model IV—
P/IV—
Market implies +49.3%/yr vs model +8.0% · above model
XP
XP Inc.
Valuation N/A
Financial Services
Price$19.86
Model IV—
P/IV—
XPEL
XPEL, Inc.
Fairly valued
Industrials
Price$47.20
Model IV$45.91
P/IV1.00
Premium +3% Return to IV: -2.7%
Owner yield 3.5% 10-yr IRR 8.5% · grower
Market implies +9.8%/yr vs model +13.3% · below model
XPER
Xperi Inc.
Deeply undervalued
Technology
Price$5.75
Model IV$8.39
P/IV0.95
Discount 31% Return to IV: +45.9%
Market implies -5.0%/yr vs model +2.0% · below model
XPEV
XPENG INC.
Valuation N/A
Consumer Cyclical
Price$10.71
Model IV—
P/IV—
Market implies +72.9%/yr vs model +8.0% · above model
XPL
SOLITARIO RESOURCES CORP.
Valuation N/A
Basic Materials
Price$0.62
Model IV—
P/IV—
Market implies +29.7%/yr vs model +5.0% · above model
XPO
XPO, Inc.
Valuation N/A
Industrials
Price$182.18
Model IV—
P/IV—
Market implies +32.3%/yr vs model +4.0% · above model
XPOF
Xponential Fitness, Inc.
Deeply undervalued
Communication Services
Price$4.11
Model IV$5.40
P/IV0.21
Discount 24% Return to IV: +31.4%
Owner yield 13.3% 10-yr IRR 32.0% · grower
Market implies +4.4%/yr vs model +16.0% · below model
XPON
Expion360 Inc.
Deeply undervalued
Technology
Price$5.07
Model IV$1.39
P/IV0.38
Premium +265% Return to IV: -72.6%
Market implies +22.2%/yr vs model +20.9% · in line
XPRO
EXPRO GROUP HOLDINGS N.V.
Deeply overvalued
Energy
Price$17.58
Model IV$8.29
P/IV1.78
Premium +112% Return to IV: -52.9%
Market implies +15.6%/yr vs model +8.0% · above model
XRAY
DENTSPLY SIRONA Inc.
Deeply overvalued
Healthcare
Price$10.46
Model IV$4.64
P/IV2.26
Premium +125% Return to IV: -55.6%
Owner yield 9.8% 10-yr IRR 17.8% · steady
Market implies +16.2%/yr vs model +5.5% · above model
XRN
Chiron Real Estate Inc.
Valuation N/A
Financial Services
Price$35.99
Model IV—
P/IV—
XRP
Bitwise XRP ETF
Valuation N/A
Financial Services
Price$12.08
Model IV—
P/IV—
XRPN
Armada Acquisition Corp. II
Valuation N/A
Financial Services
Price$10.55
Model IV—
P/IV—
XRPZ
Franklin XRP Trust
Fairly valued
Financial Services
Price$14.78
Model IV$11.50
P/IV1.02
Premium +29% Return to IV: -22.2%
XRTX
XORTX Therapeutics Inc.
Valuation N/A
Healthcare
Price$2.07
Model IV—
P/IV—
XRX
Xerox Holdings Corp
Valuation N/A
Technology
Price$3.43
Model IV—
P/IV—
Market implies -14.6%/yr vs model +7.6% · below model
XRXDW
Xerox Holdings Corp
Valuation N/A
Technology
Price$0.35
Model IV—
P/IV—
Market implies -50.0%/yr vs model +7.6% · below model
XSLL
Xsolla SPAC 1
Valuation N/A
Financial Services
Price$10.00
Model IV—
P/IV—
XTIA
XTI Aerospace, Inc.
Deeply undervalued
Technology
Price$1.01
Model IV$1.89
P/IV0.96
Discount 46% Return to IV: +86.8%
Market implies -13.3%/yr vs model +8.9% · below model
XTLB
XTL BIOPHARMACEUTICALS LTD
Valuation N/A
Healthcare
Price$2.56
Model IV—
P/IV—
Market implies +147.5%/yr vs model +15.0% · above model
XTNT
Xtant Medical Holdings, Inc.
Deeply undervalued
Healthcare
Price$0.35
Model IV$1.96
P/IV0.24
Discount 82% Return to IV: +467.8%
Market implies -9.4%/yr vs model +20.3% · below model
XWEL
XWELL, Inc.
Valuation N/A
Consumer Cyclical
Price$0.96
Model IV—
P/IV—
Market implies -11.0%/yr vs model +2.0% · below model
XXI
Twenty One Capital, Inc.
Valuation N/A
Financial Services
Price$5.79
Model IV—
P/IV—